Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

2138.4000 21.40 (1.01%)

NSE Sep 05, 2025 15:31 PM

33.73% Gain from 52W Low

Volume: 48,681

Caplin Point Laboratories Ltd.

03 Sep 2025

2138.40

1.01%

Company Update

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press release - Receipt of USFDA Approval

More from Caplin Point Laboratories Ltd.

Recommended

Five Interesting Stocks Today - September 5, 2025

The Baseline | 05 Sep 2025, 04:37PM

Market closes flat, Softbank Group sells a 2.2% stake in Ola Electric through the open market

Trendlyne Marketwatch | 05 Sep 2025, 03:58PM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets